Back to Journals » OncoTargets and Therapy » Volume 10

Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib

Total article views   Abstract views HTML views PDF downloads Totals
11,835 Dovepress* 7,104 2,871+ 1,186 9,975
PubMed Central* 0 1,860 708 1,860
Totals 7,104 4,731 1,894 11,835
*Since 10 July 2017
+Since July 2016

View citations on PubMed Central and Google Scholar